ID:CD80_HUMAN DESCRIPTION: RecName: Full=T-lymphocyte activation antigen CD80; AltName: Full=Activation B7-1 antigen; AltName: Full=BB1; AltName: Full=CTLA-4 counter-receptor B7.1; Short=B7; AltName: CD_antigen=CD80; Flags: Precursor; FUNCTION: Involved in the costimulatory signal essential for T- lymphocyte activation. T-cell proliferation and cytokine production is induced by the binding of CD28 or CTLA-4 to this receptor. SUBUNIT: Interacts with adenovirus subgroup B fiber proteins and acts as a receptor for these viruses. INTERACTION: Q9NZQ7:CD274; NbExp=2; IntAct=EBI-1031024, EBI-4314282; P16410:CTLA4; NbExp=3; IntAct=EBI-1031024, EBI-1030991; P08138:NGFR; NbExp=3; IntAct=EBI-1031024, EBI-1387782; SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. TISSUE SPECIFICITY: Expressed on activated B-cells, macrophages and dendritic cells. SIMILARITY: Contains 1 Ig-like C2-type (immunoglobulin-like) domain. SIMILARITY: Contains 1 Ig-like V-type (immunoglobulin-like) domain.
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P33681
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0009967 positive regulation of signal transduction GO:0016032 viral process GO:0019221 cytokine-mediated signaling pathway GO:0031295 T cell costimulation GO:0035556 intracellular signal transduction GO:0045086 positive regulation of interleukin-2 biosynthetic process GO:0045425 positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process GO:0045627 positive regulation of T-helper 1 cell differentiation GO:0045893 positive regulation of transcription, DNA-templated GO:0046718 viral entry into host cell GO:0046854 phosphatidylinositol phosphorylation GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation GO:0051897 positive regulation of protein kinase B signaling
BC042665 - Homo sapiens CD80 molecule, mRNA (cDNA clone MGC:34467 IMAGE:5181343), complete cds. AK292129 - Homo sapiens cDNA FLJ75225 complete cds, highly similar to Homo sapiens CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) (CD80), mRNA. M27533 - Human Ig rearranged B7 protein mRNA VC1-region, complete cds. AY197777 - Homo sapiens costimulatory factor CD80 type 1 mRNA, complete cds; alternatively spliced. AY197778 - Homo sapiens costimulatory factor CD80 type 2 mRNA, complete cds; alternatively spliced. KJ890861 - Synthetic construct Homo sapiens clone ccsbBroadEn_00255 CD80 gene, encodes complete protein. AB590671 - Synthetic construct DNA, clone: pFN21AE1779, Homo sapiens CD80 gene for CD80 molecule, without stop codon, in Flexi system. AY081815 - Homo sapiens costimulatory molecule variant IgV-CD80 (CD80) mRNA, complete cds, alternatively spliced. JD213996 - Sequence 195020 from Patent EP1572962. JD534344 - Sequence 515368 from Patent EP1572962. JD358672 - Sequence 339696 from Patent EP1572962. JD078293 - Sequence 59317 from Patent EP1572962. JD184529 - Sequence 165553 from Patent EP1572962. JD315702 - Sequence 296726 from Patent EP1572962. JD075425 - Sequence 56449 from Patent EP1572962. JD531160 - Sequence 512184 from Patent EP1572962. JD482886 - Sequence 463910 from Patent EP1572962. JD279138 - Sequence 260162 from Patent EP1572962. JD414203 - Sequence 395227 from Patent EP1572962. JD160060 - Sequence 141084 from Patent EP1572962. JD315159 - Sequence 296183 from Patent EP1572962. JD544794 - Sequence 525818 from Patent EP1572962. JD099884 - Sequence 80908 from Patent EP1572962. JD195205 - Sequence 176229 from Patent EP1572962. JD248995 - Sequence 230019 from Patent EP1572962. JD274360 - Sequence 255384 from Patent EP1572962. JD153520 - Sequence 134544 from Patent EP1572962. JD268603 - Sequence 249627 from Patent EP1572962. JD327957 - Sequence 308981 from Patent EP1572962.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_asbcellPathway - Antigen Dependent B Cell Activation h_blymphocytePathway - B Lymphocyte Cell Surface Molecules h_ctla4Pathway - The Co-Stimulatory Signal During T-cell Activation
Reactome (by CSHL, EBI, and GO)
Protein P33681 (Reactome details) participates in the following event(s):